C7n_w8QW4AAOfl_

Did You Know? The Straight Facts about the Metabolic Disease Epidemic in Asia

mildred Uncategorised Leave a Comment

Metabolic diseases are one of many healthcare threats faced by the region, and Johnson & Johnson Innovation is committed to working with local governments, industry experts and innovators to develop solutions for patients across the region. Singapore is one of the major innovation hotspots where Johnson & Johnson Innovation is heavily investing efforts to strengthen its entrepreneurial ecosystem, beginning with …

Header

Johnson & Johnson Innovation Strengthens Innovation Hubs in Asia Pacific through Singapore QuickFire Challenge – Metabolic Disease Innovation

mildred Uncategorised Leave a Comment

Asia Pacific is a region changing at a sometimes dizzying pace. Already comprising 60% of the world’s population, it is growing by some 14 million people per year.  Urbanisation is happening at a pace the world has never seen before,  allowing the equally unprecedented growth of the middle class.  Add to the mix some of the world’s most aging populations, …

lab technician pipette liquid into test tubes

Download inVentiv Health’s whitepaper on Understanding the Continuum of Clinical Collaboration: Maximizing Partner Relationships and Unlocking Greater Value

mildred Uncategorised Leave a Comment

As biopharma companies evaluate strategies to advance their products to market, they are increasingly doing so with new options on partnership.  CRO or Vendor partners are invited to solve challenges of capacity, quality, expertise, and infrastructure – but not necessarily all at the same time.  Effective solutions are therefore about taking the BEST approach (Blended Efficient Sustainable Team) that may …

lumosa

Sponsored Blogpost

mildred Uncategorised Leave a Comment

COMPANY INTRODUCTION Lumosa Therapeutics is dedicated to the development of innovative new drugs for the treatment of neurological and inflammatory diseases with unmet medical needs. The company is actively engaged in scientific licensing and new drug development under the “RESEARCH and DEVELOPMENT” model. This model is executed by a highly capable and experienced multi-functional team of translational research, CMC, preclinical, …

Biopolis_Running Man 1600

Biopolis – Asia’s Premier Biomedical Hub

mildred Uncategorised Leave a Comment

  As the lead government agency responsible for the development of industrial infrastructure to support and catalyse the growth of industries and enterprises in Singapore, JTC has pioneered and developed innovative infrastructure solutions to meet the unique needs of the biomedical industry. One of these is Biopolis @ one-north, a world-class, purpose-built biomedical research and development hub. With 13 buildings …

Rare Disease Day – The Fight Against Rare Diseases

mildred Uncategorised Leave a Comment

First launched by EURORDIS and its Council of National Alliances in 2008, Rare Disease Day is now in its 9th year and is recognized in over 80 countries on the last day of February each year. The main objective of Rare Disease Day is to raise awareness amongst the general public and decision-makers about rare diseases and their impact on …

Capture 2

Maximizing injectables production: Enabling consistent supply

mildred Uncategorised Leave a Comment

One of the most significant trends today in our industry is the enormous growth of the injectable market. Injectables are becoming the single largest driver of the pharma/biotech market and offer tremendous opportunity. However, bringing an injectable to market is no small feat. Staying competitive, once in the market, can be just as challenging. Market and regulatory requirements regarding safety …

Capture 1

Meeting the inherent challenges of complex drug substances

mildred Uncategorised Leave a Comment

Realizing the full potential of a novel injectable drug compound is no small task. In the months and years that lead from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can slow development to a halt, often at key stages. A careful, systematic approach to identifying where and why these roadblocks …